Viewing Study NCT05816057


Ignite Creation Date: 2025-12-24 @ 6:41 PM
Ignite Modification Date: 2025-12-28 @ 8:21 PM
Study NCT ID: NCT05816057
Status: COMPLETED
Last Update Posted: 2024-01-03
First Post: 2023-02-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Efficacy and Safety of Semaglutide Injection in the Treatment of Type 2 Diabetes Mellitus
Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module